Literature DB >> 29563354

Adiponectin in Chronic Thromboembolic Pulmonary Hypertension.

Sarasa Isobe1, Masaharu Kataoka1, Takashi Kawakami1, Keiichi Fukuda1.   

Abstract

BACKGROUND: The correlation between serum adiponectin concentration and hemodynamics or certain metabolic markers in patients with chronic thromboembolic pulmonary hypertension (CTEPH) is unknown.Methods and 
Results: We enrolled 30 CTEPH patients who underwent interventional therapy of balloon pulmonary angioplasty or pulmonary endarterectomy. Serum adiponectin concentrations positively correlated with B-type natriuretic peptide (BNP) concentrations, pulmonary vascular resistance, and mean pulmonary arterial pressure. After the therapeutic interventions, serum adiponectin concentrations improved and changes in serum adiponectin concentrations significantly correlated with changes in BNP concentrations.
CONCLUSIONS: Adiponectin can be a useful marker for the severity of CTEPH.

Entities:  

Keywords:  Adiponectin; B-type natriuretic peptide; Chronic thromboembolic pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 29563354     DOI: 10.1253/circj.CJ-17-1434

Source DB:  PubMed          Journal:  Circ J        ISSN: 1346-9843            Impact factor:   2.993


  3 in total

1.  High plasma adiponectin is associated with increased pulmonary blood flow and reduced right ventricular function in patients with pulmonary hypertension.

Authors:  Dongling Luo; Pengyuan Chen; Ziyang Yang; Yongheng Fu; Yigao Huang; Hezhi Li; Jimei Chen; Jian Zhuang; Caojin Zhang
Journal:  BMC Pulm Med       Date:  2020-07-30       Impact factor: 3.317

2.  Association of plasma adiponectin with pulmonary hypertension, mortality and heart failure in African Americans: Jackson Heart Study.

Authors:  Suvasini Lakshmanan; Matthew Jankowich; Wen-Chih Wu; Siddique Abbasi; Alan R Morrison; Gaurav Choudhary
Journal:  Pulm Circ       Date:  2020-11-11       Impact factor: 3.017

Review 3.  Circulating Blood-Based Biomarkers in Pulmonary Hypertension.

Authors:  Marta Banaszkiewicz; Aleksandra Gąsecka; Szymon Darocha; Michał Florczyk; Arkadiusz Pietrasik; Piotr Kędzierski; Michał Piłka; Adam Torbicki; Marcin Kurzyna
Journal:  J Clin Med       Date:  2022-01-13       Impact factor: 4.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.